"I just sent off the guests from all over the world, and ushered in guests from all over the world." On September 26~30, 2017, the 20th National Congress of Clinical Oncology and the 2017 CSCO Annual Meeting (CSCO 2017) was held in the beautiful and colorful coastal city of Xiamen International Convention and Exhibition Center. This city, which has just attracted the attention of the global political and economic circles due to the 9th BRICS Leaders' Summit, has become the focus of the clinical oncology community in China and even the world. More than 30,000 conference delegates, including clinicians and researchers in the field of oncology from all over the country, more than 700 domestic and foreign speakers, and representatives of more than 190 pharmaceutical companies and media, gathered together to participate in the largest and highest level academic event in the field of clinical oncology in China.
During the conference on September 27, Mengyang Pharmaceutical held a kick-off meeting for the "Multi-center Clinical Study of Post-marketing Re-evaluation of Shengbai Oral Liquid". Experts from 18 tertiary hospitals across the country, including Guang'anmen Hospital of China Academy of Chinese Medical Sciences, No. 81 Hospital of the Chinese People's Liberation Army, Peking University Cancer Hospital, First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, and Yueyang Hospital of Integrated Traditional Chinese and Western Medicine affiliated to Shanghai University of Traditional Chinese Medicine, attended the meeting.
The kick-off meeting was chaired by Mr. Wang Yongjun, Director of Medical Marketing. Mr. Zhang Min, chairman of the board of directors, made a warm welcome speech and expressed his deep gratitude to the experts of the scientific research project team. The experts at the meeting gave a detailed introduction to the development status and future development plan of Mengyang Pharmaceutical, and hoped to bring Shengbai Oral Liquid to a new development track through this scientific research project.
Professor Lin Hongsheng of Guanganmen Hospital, China Academy of Chinese Medical Sciences, the leader of the scientific research project, made detailed communication with the participating experts on the details of the selection criteria, group drug selection, observation indicators and other details in the project, Professor Hua Haiqing of the 81st Hospital of the Chinese People's Liberation Army, Professor Li Pingping of Peking University Cancer Hospital, Professor Wang Shenyu of Liaoning Cancer Hospital, Professor Xu Yun from Xiyuan Hospital, China Academy of Chinese Medical Sciences and other experts also made wonderful speeches, and experts said that the initiation of this project has long-term guiding significance for the prevention and treatment of raw white oral liquid in the prevention and treatment of leukopenia caused by tumor radiotherapy and chemotherapy, and will also provide strong evidence-based medical data support for the application of traditional Chinese medicine in the treatment of tumor radiotherapy and chemotherapy in Western medicine.
Professor Lin Hongsheng finally emphasized that the development of this scientific research project is to inherit the classic drugs with Chinese medicine characteristics of the older generation of Chinese medicine experts. Second, because Shengbai Oral Liquid can prove its clinical efficacy by using biochemical index data, traditional Chinese medicine products such as Shengbai Oral Liquid will be verified again with modern scientific research methods and rigorous scientific research methods, so that more Western medicine doctors or foreign doctors can fully understand the exact efficacy of traditional Chinese medicine, and push traditional Chinese medicine to a new height and go to the world in a real sense.
The successful holding of the kick-off meeting of the "Post-marketing Re-evaluation Multi-center Clinical Study of Shengbai Oral Liquid" attracted the attention and interviews of many media on the scene, and Professor Lin Hongsheng also accepted an interview and report by the reporter of the Physician Daily after the meeting.
The kick-off meeting responded to the theme of the 20th CSCO Conference "Inheritance and Innovation, Hand in Hand", promoted academic exchanges and scientific research cooperation in the field of clinical oncology in many provinces and cities, and actively promoted the development of traditional Chinese medicine oncology.
